{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:42:15Z","timestamp":1790106135563,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) is associated with an increased risk of cardiovascular disease (CVD) linked to atherogenic dyslipidaemia and postprandial hyperlipidaemia. Alirocumab, a proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitor, improves CVD risk by reducing the concentration of low\u2010density lipoprotein\u2010cholesterol (LDL\u2010C). However, effects of PCK9 inhibitors on other aspects of diabetic dyslipidaemia, particularly in the postprandial situation, are less clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods<\/jats:title>\n                    <jats:p>Twelve male patients with T2DM on an intensive insulin regimen completed a 6\u2010week randomized, double\u2010blind, placebo\u2010controlled, proof\u2010of\u2010concept study. Participants received three biweekly dosages of subcutaneous alirocumab (150\u2009mg) or placebo. Before and after the intervention, fasting and postprandial triglyceride (TG) plasma levels, apolipoprotein (apo) B48, lipoprotein composition isolated by ultracentrifugation, vascular function and markers of inflammation were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Alirocumab treatment reduced fasting plasma TG levels (between group median change \u221224.7%;\n                      <jats:italic>P<\/jats:italic>\n                      =\u20090.018) and fasting apoB48 serum levels (\u221235.9%;\n                      <jats:italic>P<\/jats:italic>\n                      =\u20090.039) compared with placebo. Alirocumab reduced the plasma TG area under the curve (AUC) (\u221226.4%;\n                      <jats:italic>P<\/jats:italic>\n                      =\u20090.006) and apoB48 AUC (\u221255.7%;\n                      <jats:italic>P<\/jats:italic>\n                      =\u20090.046), as well as plasma TG incremental AUC (\u221221.4%;\n                      <jats:italic>P<\/jats:italic>\n                      =\u20090.04) and apoB48 incremental AUC (\u221226.8%;\n                      <jats:italic>P<\/jats:italic>\n                      =\u20090.02). In addition, alirocumab reduced fasting and postprandial TG levels in very low\u2010density lipoprotein (VLDL) and LDL. Alirocumab improved fasting pulse wave velocity, but no changes in postprandial markers of inflammation were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In addition to the well\u2010known LDL\u2010C\u2010reducing effects, 6\u2009weeks of alirocumab treatment lowered both fasting and postprandial plasma TG levels by reducing the TG levels in VLDL and LDL and the concentration of intestinal remnants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.13960","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T23:40:46Z","timestamp":1578440446000},"page":"807-816","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A placebo\u2010controlled proof\u2010of\u2010concept study of alirocumab on postprandial lipids and vascular elasticity in insulin\u2010treated patients with type 2 diabetes mellitus"],"prefix":"10.1111","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3935-1233","authenticated-orcid":false,"given":"Benjamin","family":"Burggraaf","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Center for Diabetes and Vascular Medicine Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine M.C.","family":"Pouw","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador Fern\u00e1ndez","family":"Arroyo","sequence":"additional","affiliation":[{"name":"Departament de Medicina i Cirurgia Unitat de Recerca Biom\u00e8dica, Universitat Rovira i Virgili  Tarragona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie C.","family":"van Vark\u2010van der Zee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pharmacology Vascular and Metabolic Diseases, Erasmus University Medical Center  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert\u2010Jan M.","family":"van de Geijn","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Birnie","sequence":"additional","affiliation":[{"name":"Department of Statistics and Education, Franciscus Academy Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"},{"name":"Department of Genetics University Medical Center Groningen, University of Groningen  Groningen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine","family":"Huisbrink","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"van der Zwan","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique T.","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pharmacology Vascular and Metabolic Diseases, Erasmus University Medical Center  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-4988","authenticated-orcid":false,"given":"Patrick C.N.","family":"Rensen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology Leiden University Medical Center  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-5165","authenticated-orcid":false,"given":"Wouter W.","family":"de Herder","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Section of Endocrinology, Erasmus University Medical Center  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Castro","family":"Cabezas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Center for Diabetes and Vascular Medicine Franciscus Gasthuis &amp; Vlietland  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60768-0"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.18574"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60104-X"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608664"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1111-y"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01831-8"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.777334"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.3.299"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(94)90085-X"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.159749"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.07.004"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M200419-JLR200"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.215434"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00760-6"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00415-9"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.3.309"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.621"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300011-JLR200"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.310882"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2000.7744"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.11.001"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02396.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2008.06.005"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)33334-4"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801174"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30313-3"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2012.05.011"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025253"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-00684"},{"issue":"3","key":"e_1_2_7_32_1","first-page":"992","article-title":"Effect of a single dose of Vitamin D3 on postprandial arterial stiffness and inflammation in Vitamin D\u2010deficient women","volume":"102","author":"De Vries MA","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2014.29"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2004.08.008"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12643"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3525-8"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107334"},{"issue":"1","key":"e_1_2_7_38_1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-2275(20)37637-9","article-title":"Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron\u2010like triglyceride emulsion reflects competition for a common lipolytic pathway","volume":"37","author":"Bjorkegren J","year":"1996","journal-title":"J Lipid Res."},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.220988"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708098200"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M400009-JLR200"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13537"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00341-X"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.15.5.551"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200011000-00011"},{"key":"e_1_2_7_46_1","article-title":"Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease","author":"Nakamura T","year":"2019","journal-title":"J Cardiol."},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.06.045"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-07320-0_12"},{"key":"e_1_2_7_49_1","article-title":"Understanding postprandial inflammation and its relationship to lifestyle behaviour and metabolic diseases","volume":"2012","author":"Klop B","year":"2012","journal-title":"Int J Vasc Med."},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-4-934"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2016.12.016"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdom.13960","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dom.13960","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dom.13960","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.13960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:41:20Z","timestamp":1761892880000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.13960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1111\/dom.13960"],"URL":"https:\/\/doi.org\/10.1111\/dom.13960","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/DOM.13960\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.13960\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.13960\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/DOM.13960\/v2\/response1","asserted-by":"object"}]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"2019-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}